HRTX Heron Therapeutics, Inc.
$0.29
Heron Therapeutics, Inc. (HRTX) Earnings News
Earnings press releases, previews and reviews for Heron Therapeutics, Inc. (HRTX), newest first. Our most recent is preview: Heron's Third-Quarter Report Hinges on Sinvanti's Defense, Covenant Headroom and a Strategic Review.
Monday
November 2, 2026
12:51 PM ET
Heron's Third-Quarter Report Hinges on Sinvanti's Defense, Covenant Headroom and a Strategic Review
Earnings Whispers · Preview
Monday
October 26, 2026
8:09 PM ET
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Monday
August 10, 2026
8:00 AM ET
Heron Therapeutics Announces Second Quarter 2026 Financial Results
Monday
July 27, 2026
8:30 AM ET
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
Monday
May 11, 2026
8:00 AM ET
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance